Today’s Stock On Watch: Will ICU Medical, Incorporated Go Down Anytime Soon?

Today's Stock On Watch: Will ICU Medical, Incorporated Go Down Anytime Soon?

The stock of ICU Medical, Incorporated (NASDAQ:ICUI) is a huge mover today! About 653,733 shares traded hands or 598.03% up from the average. ICU Medical, Incorporated (NASDAQ:ICUI) has risen 36.99% since March 3, 2016 and is uptrending. It has outperformed by 28.64% the S&P500.
The move comes after 7 months positive chart setup for the $2.27 billion company. It was reported on Oct, 6 by We have $171.41 PT which if reached, will make NASDAQ:ICUI worth $499.40M more.

Analysts await ICU Medical, Incorporated (NASDAQ:ICUI) to report earnings on November, 3. They expect $0.92 earnings per share, up 5.75% or $0.05 from last year’s $0.87 per share. ICUI’s profit will be $14.86 million for 38.18 P/E if the $0.92 EPS becomes a reality. After $0.98 actual earnings per share reported by ICU Medical, Incorporated for the previous quarter, Wall Street now forecasts -6.12% negative EPS growth.

ICU Medical, Incorporated (NASDAQ:ICUI) Ratings Coverage

Out of 4 analysts covering ICU Medical (NASDAQ:ICUI), 4 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. ICU Medical has been the topic of 8 analyst reports since August 11, 2015 according to StockzIntelligence Inc. As per Tuesday, August 11, the company rating was maintained by Roth Capital. Gabelli initiated the shares of ICUI in a report on Friday, March 11 with “Buy” rating. As per Monday, August 17, the company rating was upgraded by Zacks. Piper Jaffray maintained it with “Overweight” rating and $124 target price in Tuesday, August 11 report. The stock has “Buy” rating given by Roth Capital on Friday, November 6. The stock of ICU Medical, Incorporated (NASDAQ:ICUI) earned “Buy” rating by TH Capital on Tuesday, August 11. As per Friday, November 6, the company rating was maintained by TH Capital.

According to Zacks Investment Research, “ICU Medical, Inc., together with its wholly-owned subsidiary Budget Medical Products, Inc. is a leader in the development, manufacture and sale of proprietary, disposable medical connection systems for use in intravenous therapy applications. The company’s intravenous connectors are designed to prevent accidental disconnection’s of intravenous lines and to protect healthcare workers and their patients from the spread of infectious diseases such as Hepatitis B and Human Immunodeficiency Virus by significantly reducing the risk of accidental needlesticks.”

Insitutional Activity: The institutional sentiment increased to 1.02 in Q2 2016. Its up 0.11, from 0.91 in 2016Q1. The ratio is positive, as 14 funds sold all ICU Medical, Incorporated shares owned while 76 reduced positions. 20 funds bought stakes while 72 increased positions. They now own 14.20 million shares or 0.50% more from 14.13 million shares in 2016Q1.
Fisher Asset Ltd Liability accumulated 0.01% or 31,000 shares. Aqr Cap Management holds 0.01% or 28,935 shares in its portfolio. Suntrust Banks has 2,577 shares for 0% of their US portfolio. The California-based Schwab Charles Investment Inc has invested 0.01% in ICU Medical, Incorporated (NASDAQ:ICUI). Waddell & Reed Fincl has 47,100 shares for 0.01% of their US portfolio. Thrivent For Lutherans holds 7,000 shares or 0% of its portfolio. Ahl Partners Limited Liability Partnership holds 0.13% of its portfolio in ICU Medical, Incorporated (NASDAQ:ICUI) for 22,041 shares. Tci Wealth Advsrs has 5 shares for 0% of their US portfolio. The North Carolina-based First Citizens Natl Bank And Communications has invested 0.05% in ICU Medical, Incorporated (NASDAQ:ICUI). Sg Americas Securities Limited Liability Company accumulated 0.02% or 27,209 shares. Wells Fargo & Communication Mn holds 0.01% of its portfolio in ICU Medical, Incorporated (NASDAQ:ICUI) for 241,724 shares. American Group, a New York-based fund reported 10,904 shares. Bancorp Of America De accumulated 42,325 shares or 0% of the stock. Creative Planning accumulated 59 shares or 0% of the stock. Hbk Invests L P holds 0.01% of its portfolio in ICU Medical, Incorporated (NASDAQ:ICUI) for 6,666 shares.

Insider Transactions: Since April 11, 2016, the stock had 0 insider buys, and 15 sales for $16.94 million net activity. $190,125 worth of shares were sold by SWINNEY ROBERT S on Monday, May 9. 7,268 shares were sold by Jain Vivek, worth $903,019. The insider SAUCEDO JOSEPH R sold $1.00M. Sanzone Virginia Ruth sold $230,824 worth of stock or 1,903 shares. Shares for $261,096 were sold by McCall Thomas D. Lamb Scott E sold $179,255 worth of ICU Medical, Incorporated (NASDAQ:ICUI) on Tuesday, September 13. $5.45M worth of ICU Medical, Incorporated (NASDAQ:ICUI) was sold by RIGGS STEVEN.

More recent ICU Medical, Incorporated (NASDAQ:ICUI) news were published by: which released: “ICU Medical To Buy Pfizer Unit in $1 Billion Deal” on October 06, 2016. Also published the news titled: “ICU Medical to buy Pfizer’s infusion therapy business for $1 bln” on October 06, 2016.‘s news article titled: “B. Braun and ICU Medical Sign Expanded Long-Term International Distribution …” with publication date: March 21, 2016 was also an interesting one.

ICUI Company Profile

ICU Medical, Inc., incorporated on January 9, 1992, is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems. The Firm operates through the segment, which is engaged in the development, manufacturing and sale of medical technologies used in infusion therapy, critical care and oncology applications. The Company’s products are used in acute care hospitals and ambulatory clinics in over 60 countries around the world.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment